Loss-of-function mutations of SCN9A were associated with congenital insensitivity to pain [17], while gain-of-function mutations of this gene were associated with neuropathic pain syndromes, including erythromelalgia, paroxysmal extreme pain disorder, and small-fiber neuropathy [18,19]. The gene discussed is SCN9A; the disease is paroxysmal extreme pain disorder.